Technical Analysis for CRSP - CRISPR Therapeutics AG
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Historical CRSP trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| New 52 Week Closing High | Bullish | -4.84% | |
| New 52 Week High | Strength | -4.84% | |
| Upper Bollinger Band Walk | Strength | -4.84% | |
| Multiple of Ten Bullish | Other | -4.84% | |
| Wide Bands | Range Expansion | -4.84% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Trending on StockTwits | 1 day ago | |
| 60 Minute Opening Range Breakdown | 2 days ago | |
| Down 5% | 2 days ago | |
| Down 3% | 2 days ago | |
| Down 2 % | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/10/2021
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering CRISPR Genome Editing Cas9 The Dna
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering CRISPR Genome Editing Cas9 The Dna
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 220.15 |
| 52 Week Low | 32.3 |
| Average Volume | 1,786,496 |
| 200-Day Moving Average | 93.71 |
| 50-Day Moving Average | 142.80 |
| 20-Day Moving Average | 173.65 |
| 10-Day Moving Average | 185.37 |
| Average True Range | 14.16 |
| ADX | 42.75 |
| +DI | 38.41 |
| -DI | 10.52 |
| Chandelier Exit (Long, 3 ATRs ) | 177.66 |
| Chandelier Exit (Short, 3 ATRs ) | 186.68 |
| Upper Bollinger Band | 209.40 |
| Lower Bollinger Band | 137.90 |
| Percent B (%b) | 0.87 |
| BandWidth | 41.17 |
| MACD Line | 16.06 |
| MACD Signal Line | 13.89 |
| MACD Histogram | 2.165 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 231.59 | ||||
| Resistance 3 (R3) | 234.82 | 227.49 | 226.30 | ||
| Resistance 2 (R2) | 227.49 | 219.41 | 225.87 | 224.54 | |
| Resistance 1 (R1) | 213.68 | 214.42 | 210.02 | 210.45 | 222.78 |
| Pivot Point | 206.35 | 206.35 | 204.51 | 204.73 | 206.35 |
| Support 1 (S1) | 192.54 | 198.27 | 188.88 | 189.31 | 176.98 |
| Support 2 (S2) | 185.21 | 193.28 | 183.59 | 175.22 | |
| Support 3 (S3) | 171.40 | 185.21 | 173.46 | ||
| Support 4 (S4) | 168.17 |
